Answer
The safety and efficacy of siltuximab in children aged 17 years or younger have not been established, and no data are available.
Sources for this answer
- SYLVANT 100 mg powder for concentrate for solution for infusionRecordati UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 12Document updated
Sources checked